Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease

被引:7
|
作者
Araki, Takako [1 ]
Liu, Ning-Ai [2 ]
机构
[1] Univ Minnesota, Dept Med, Div Diabet Endocrinol & Metab, Box 736 UMHC, Minneapolis, MN 55455 USA
[2] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA
来源
FRONTIERS IN ENDOCRINOLOGY | 2018年 / 9卷
关键词
pituitary tumor; Cushing disease; cell cycle; cyclin E; E2F1; POMC; MULTIPLE ENDOCRINE NEOPLASIA; HUMAN PITUITARY-ADENOMAS; RETINOBLASTOMA SUSCEPTIBILITY GENE; GROWTH-FACTOR RECEPTOR; TUMOR-SUPPRESSOR GENE; DEPENDENT KINASES; INHIBITOR P27; CORTICOTROPH TUMORS; CDK INHIBITOR; MICE LACKING;
D O I
10.3389/fendo.2018.00444
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cell cycle proteins are critical to pituitary development, but their contribution to lineage-specific tumorigenesis has not been well-elucidated. Emerging evidence from in vitro human tumor analysis and transgenic mouse models indicates that G1/S-related cell cycle proteins, particularly cyclin E, p27, Rb, and E2F1, drive molecular mechanisms that underlie corticotroph-specific differentiation and development of Cushing disease. The aim of this review is to summarize the literature and discuss the complex role of cell cycle regulation in Cushing disease, with a focus on identifying potential targets for therapeutic intervention in patients with these tumors.
引用
收藏
页数:8
相关论文
共 35 条
  • [1] Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation
    Furukawa, Y
    Kikuchi, J
    Nakamura, M
    Iwase, S
    Yamada, H
    Matsuda, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (03) : 663 - 673
  • [2] High-throughput Screening for Cushing Disease: Therapeutic Potential of Thiostrepton via Cell Cycle Regulation
    Hakata, Takuro
    Yamauchi, Ichiro
    Kosugi, Daisuke
    Sugawa, Taku
    Fujita, Haruka
    Okamoto, Kentaro
    Ueda, Yohei
    Fujii, Toshihito
    Taura, Daisuke
    Inagaki, Nobuya
    ENDOCRINOLOGY, 2024, 165 (09)
  • [4] LINEAGE-SPECIFIC REGULATION OF CELL-CYCLE GENE-EXPRESSION IN DIFFERENTIATING MYELOID CELLS
    BURGER, C
    WICK, N
    MULLER, R
    JOURNAL OF CELL SCIENCE, 1994, 107 : 2047 - 2054
  • [5] Tumor-Directed Therapeutic Targets in Cushing Disease
    Theodoropoulou, Marily
    Reincke, Martin
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (03) : 925 - 933
  • [6] Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells
    Chang, Yun
    Hellwarth, Peter B.
    Randolph, Lauren N.
    Sun, Yufei
    Xing, Yuxian
    Zhu, Wuqiang
    Lian, Xiaojun Lance
    Bao, Xiaoping
    BIOTECHNOLOGY AND BIOENGINEERING, 2020, 117 (07) : 2177 - 2186
  • [7] Lineage-Specific Early Differentiation of Human Embryonic Stem Cells Requires a G2 Cell Cycle Pause
    Van Oudenhove, Jennifer J.
    Grandy, Rodrigo A.
    Ghule, Prachi N.
    del Rio, Roxana
    Lian, Jane B.
    Stein, Janet L.
    Zaidi, Sayyed K.
    Stein, Gary S.
    STEM CELLS, 2016, 34 (07) : 1765 - 1775
  • [8] Adult Pituitary Cell Maintenance: Lineage-Specific Contribution of Self-Duplication
    Langlais, David
    Couture, Catherine
    Kmita, Marie
    Drouin, Jacques
    MOLECULAR ENDOCRINOLOGY, 2013, 27 (07) : 1103 - 1112
  • [9] Chromatin restriction by the nucleosome remodeler Mi-2β and functional interplay with lineage-specific transcription regulators control B-cell differentiation
    Yoshida, Toshimi
    Hu, Yeguang
    Zhang, Zhihong
    Emmanuel, Akinola O.
    Galani, Kiriaki
    Muhire, Brejnev
    Snippert, Hugo J.
    Williams, Christine J.
    Tolstorukov, Michael Y.
    Gounari, Fotini
    Georgopoulos, Katia
    GENES & DEVELOPMENT, 2019, 33 (13-14) : 763 - 781
  • [10] Cell Cycle Proteins and Retinal Degeneration: Evidences of New Potential Therapeutic Targets
    Arsenijevic, Yvan
    RETINAL DEGENERATIVE DISEASES: MECHANISMS AND EXPERIMENTAL THERAPY, 2016, 854 : 371 - 377